Straumann Emdogain is a mix of enamel matrix proteins that, when applied to a clean tooth root surface or oral wound, form an extracellular matrix that stimulates cells and processes that are fundamental for periodontal regeneration and soft tissue wound healing. Numerous scientific studies provide clinical evidence of the application of Straumann Emdogain in different indications: periodontal regeneration, gingival recession, and oral wound healing. As the first dental implant company to do so, Straumann incorporates a biologic in the surgical procedure of implant placement as a standard step in order to improve wound healing.

Regeneration

By modulating the wound healing process, Emdogain induces the regeneration of a functional attachment in regenerative periodontal procedures and accelerates the soft tissue wound healing process following oral surgical procedures such as implantations.

Peace of Mind

Emdogain is backed by extensive and long-term clinical documentation. Over the past 20 years it has been used in over 2 million patients and is documented in over 1,000 scientific publications, including 600 clinical publications.

Handling

As it is a gel, Emdogain is easy to apply, even when the defect is difficult to access.

Comfort

Emdogain leads to better tooth prognosis and esthetic results. Less post-surgical discomfort such as pain or swelling is reported after a procedure with Emdogain compared to the same procedure without Emdogain.

Predictability

Emdogain leads to significantly improved clinical parameters in intraosseous defects and root coverage procedures, including in the long term, compared to the same surgical procedures without the addition of Emdogain.

More information